Veenat 400mg Tablet (Imatinib) is indicated for the treatment of various conditions in adults, children, and adolescents, including:
Additionally, Veenat 400mg Tablet is used specifically in adults for the treatment of:
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Veenat 400mg Tablet, containing Imatinib, a Tyrosine Kinase Inhibitor, is utilized to treat various conditions in adults, children, and adolescents, including:
Before initiating Veenat 400mg Tablet, disclose any history of kidney, liver, or heart issues, hepatitis B infection, or thrombotic microangiopathy to your doctor.
Pregnant and breastfeeding women should avoid VEENAT 400MG TABLET unless specifically advised by a physician. Caution is warranted in children, adolescents, and elderly individuals (aged 65 years and above).
Consult your doctor before consuming alcohol with Veenat 400.
Consult your doctor before using Veenat 400 during pregnancy as it may pose risks to the developing baby.
Avoid breastfeeding while using Veenat 400 as it may harm the baby.
Veenat 400 may cause side effects that could impair your ability to drive.
Use Veenat 400 with caution in patients with kidney disease. Dose adjustment may be necessary.
Use Veenat 400 with caution in patients with severe liver disease. Dose adjustment may be necessary.
For the treatment of cancer growth in blood, stomach, or intestine.
Inhibits the BCR-ABL tyrosine kinase, blocking proliferation and inducing apoptosis in cancer cells.
Common side effects include edema, neutropenia, nausea, muscle cramps, musculoskeletal pain, thrombocytopenia, rash, fatigue, diarrhea, headache, abdominal pain, and myalgia, among others.
Used in the treatment of chronic myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic disease, hypereosinophilic syndrome, mastocytosis, dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors.
Veenat 400mg Tablet is classified as a protein-tyrosine kinase inhibitor. Tyrosine kinases are enzymes that play a crucial role in the signaling pathways involved in cell growth and proliferation. In cancer cells, these pathways are often dysregulated, leading to uncontrolled cell growth and tumor formation.
Veenat 400mg Tablet works by inhibiting the activity of tyrosine kinases, specifically targeting the abnormal enzyme produced by cancer cells. By blocking these enzymes, Veenat 400mg Tablet interferes with the signaling pathways that promote cancer cell growth and proliferation. This ultimately leads to the suppression of cancer cell growth and may result in tumor shrinkage or slowing of disease progression.
In summary, Veenat 400mg Tablet acts by inhibiting tyrosine kinases, which are essential for the growth and survival of cancer cells, thereby helping to control the progression of cancer.
Take with food and a large glass of water.
Interactions with CYP3A4 inhibitors and inducers may affect serum levels of various drugs metabolized by CYP3A4, CYP2C9, and CYP2D6.
Avoid in case of hypersensitivity and during lactation.
Monitor for signs of severe fluid retention, cardiac disease, and increased risk for congestive heart failure. Regularly monitor CBC, liver function tests, and renal function.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.